Immunogenicity: Risk & Regulation

Immunogenicity remains a significant challenge in the development and clinical use of biologics and biosimilars. This session provides an in-depth examination of immune response mechanisms triggered by biologic therapies, including anti-drug antibody (ADA) formation and its clinical consequences. Topics include risk factors, detection methods, assay development, and predictive modeling of immunogenicity during preclinical and clinical stages. Regulatory expectations and industry best practices for immunogenicity assessment will be discussed, with an emphasis on guidance from the FDA, EMA, and WHO. The session also reviews mitigation strategies such as protein engineering, formulation optimization, and patient-specific treatment design. Real-world case studies will highlight immunogenicity concerns in therapeutic proteins, monoclonal antibodies, and biosimilar switching. This discussion is crucial for clinicians, regulatory professionals, and drug developers committed to maximizing safety and therapeutic effectiveness in biologic treatments.

    Related Conference of Immunogenicity: Risk & Regulation

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Immunogenicity: Risk & Regulation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in